Author

Gary L. Norman 1

1 Inova Diagnostics,San Diego,United States of America

GUT BARRIER FAILURE BIOMARKERS ARE ASSOCIATED WITH POOR DISEASE OUTCOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Tornai Tamás, György Kovács, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Gabor Laszlo Veres, Zakera Shums, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas, Mária Papp

IGA ANTIBODIES AGAINST FILAMENTOUS-ACTIN ARE FREQUENTLY DETECTED IN PATIENTS WITH CIRRHOSIS AND INDICATE A PROGRESSIVE DISEASE COURSE

Tornai Tamás, Boglarka Balogh, Nora Sipeki, Zsuzsanna Vitális, István Tornai, Peter Antal-Szalmas, Gary L. Norman, Tony Bruns, Mária Papp

RECONSIDERING THE PROGNOSTIC VALUE OF TRADITIONAL SEROLOGIC ANTIBODIES IN CROHN’S DISEASE – IMMUNOGLOBULIN CLASSES TO TAKE THE CENTRE STAGE

Nora Sipeki, Boglárka Suga, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Peter L Lakatos, Peter Antal-Szalmas, Mária Papp

REDISCOVERY OF THE ANTI-PANCREATIC ANTIBODIES AND EVALUATION OF THEIR PROGNOSTIC VALUE IN A PROSPECTIVE CLINICAL COHORT OF CROHN'S PATIENTS: THE IMPORTANCE OF SPECIFIC TARGET ANTIGENS (GP2 AND CUZD1).

Mária Papp, Nora Sipeki, István Ferenc Altorjay, Gary L. Norman, Zakera Shums, Dirk Roggenbuck, Kai Fechner, Peter Antal-Szalmas, Gabor Laszlo Veres, Peter L Lakatos

RISK MATRIX FOR PREDICTION OF DISEASE PROGRESSION IN A REFERRAL COHORT OF PATIENTS WITH CROHN’S DISEASE

Peter L Lakatos, Nora Sipeki, Gary L. Norman, Zakera Shums, Peter Antal-Szalmas, Gabor Laszlo Veres, Mária Papp

SIGNIFICANCE OF SEROLOGICAL MARKERS IN THE DISEASE COURSE OF ULCERATIVE COLITIS

György Kovács, Nora Sipeki, Karoly Palatka, István Ferenc Altorjay, Kai Fechner, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Peter L Lakatos, Mária Papp

TARGET-SPECIFIC ANTI-PANCREATIC ANTIBODIES ARE FREQUENT IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ASSOCIATED WITH POOR DISEASE OUTCOME

Mária Papp, Tornai Tamás, Nora Sipeki, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas

THE PREVALENCE OF ANTI-PARIETAL CELL AND ANTI-INTRINSIC FACTOR ANTIBODIES, PEPSINOGENS AND GASTRIN-17 IN CORPUS-RESTRICTED GASTRITIS PATIENTS

Petra Krike, Zakera Shums, Dace Rudzite, Inese Polaka, Sergejs Isajevs, Gary L. Norman, Marcis Leja

THE PREVALENCE OF AUTOIMMUNE GASTRITIS IN CAUCASIANS WITH GASTRIC ADENOCARCINOMA

Anete Urke, Petra Krike, Zakera Shums, Dace Rudzite, Inese Polaka, Armands Sivins, Ivans Jelovskis, Sergejs Isajevs, Inga Bogdanova, V. Boka, U. Vikmanis, Gary L. Norman, Marcis Leja

THE SEROPREVALENCE OF POSITIVE CELIAC DISEASE TESTS SUBSTANTIALLY DIFFERS DEPENDING UPON THE CRITERIA SET FOR A POSITIVE TEST RESULT

Marcis Leja, Mikus Gavars, Liene Nikitina-Zake, Gary L. Norman, Jelena Pahomova, Vilnis Dzerve, Valdis Pirags, Andrejs Erglis, Janis Klovins

Item 1 - 10 / 12
1
2